Cargando…

The efficacy and safety of bevacizumab combined with FOLFOX regimen in the treatment of advanced colorectal cancer: A systematic review and meta-analysis

BACKGROUND: It is necessary to systematically evaluate the clinical efficacy and safety of bevacizumab (BEV) combined with 5-fluorouracil + leucovorin + oxaliplatin (FOLFOX) regimen in the treatment of advanced colorectal cancer. METHODS: We searched the PubMed et al databases for randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hailing, You, Jinzhi, Liu, Wei, Chen, Dandan, Zhang, Shiqi, Wang, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322501/ https://www.ncbi.nlm.nih.gov/pubmed/34397704 http://dx.doi.org/10.1097/MD.0000000000026714

Ejemplares similares

Clinical efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
por: Du, Sihao, et al.
Publicado: (2023)

The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis
por: Wang, Zi-Xian, et al.
Publicado: (2016)

The efficacy and safety of sulindac for colorectal polyps: A protocol for systematic review and meta-analysis
por: Long, Qing, et al.
Publicado: (2020)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

A phase II clinical study of combining FOLFIRI and bevacizumab plus erlotinib in 2nd-line chemotherapy for patients with metastatic colorectal cancer
por: Zhao, Zhifei, et al.
Publicado: (2017)

The efficacy and safety of panitumumab supplementation for colorectal cancer: A meta-analysis of randomized controlled studies
por: Wang, Chengchen, et al.
Publicado: (2020)

Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials
por: Zhu, Xiaoqiang, et al.
Publicado: (2016)

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumor after failure with imatinib and sunitinib treatment: A meta-analysis
por: Zhang, Zhenan, et al.
Publicado: (2017)

Efficacy and safety of paclitaxel with or without targeted therapy as second-line therapy in advanced gastric cancer: A meta-analysis
por: Zheng, Ting, et al.
Publicado: (2020)

Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinoma: Safety and efficacy
por: Zhao, Guang Sheng, et al.
Publicado: (2017)

Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
por: Mehrzad, Valiollah, et al.
Publicado: (2016)

Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer
por: Guo, Qinghong, et al.
Publicado: (2017)

The clinical efficacy of acupoint sticking combined with massage to treatment functional dyspepsia: A protocol of systematic review and meta-analysis
por: Wu, Xiaoyan, et al.
Publicado: (2020)

Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study
por: Hosokawa, Ayumu, et al.
Publicado: (2020)

The efficacy and safety of different doses of glucocorticoid for autoimmune hepatitis: A systematic review and meta-analysis
por: Zhang, Chi, et al.
Publicado: (2019)

Atypical Reversible Leucoencephalopathy Syndrome after Bevacizumab/Folfox Regimen for Metastatic Colon Cancer
por: Salmi, Narimane, et al.
Publicado: (2014)

Efficacy of combination colonoscopy using modified cap-assisted and water-exchange colonoscopy with prone position for detection of colorectal adenomas
por: Ko, Jihwan, et al.
Publicado: (2022)

Review on comparative efficacy of bevacizumab, panitumumab and cetuximab antibody therapy with combination of FOLFOX-4 in KRAS-mutated colorectal cancer patients
por: Pathak, Surajit, et al.
Publicado: (2017)

Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
por: Cunningham, D, et al.
Publicado: (2013)

Efficacy and safety of ligation of intersphincteric fistula tract in the treatment of anal fistula: A protocol for systematic review and meta-analysis
por: Zhang, Jiaji, et al.
Publicado: (2021)

Clinical efficacy and safety of modified Sijunzi decoction for the treatment of ulcerative colitis: A protocol for a systematic review and meta-analysis
por: Tian, Shu Wei, et al.
Publicado: (2021)

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

Comparative efficacy and safety of Chinese herbal injections combined with the FOLFOX regimen for treating gastric cancer in China: a network meta-analysis
por: Zhang, Dan, et al.
Publicado: (2017)

Safety and efficacy of cold snare polypectomy for small colorectal polyps: A prospective randomized control trial and one-year follow-up study
por: Ito, Takahiro, et al.
Publicado: (2021)

MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
por: Kiss, I., et al.
Publicado: (2017)

Evaluation the efficacy and safety of simultaneous splenectomy in liver transplantation patients: A meta-analysis
por: He, Chao, et al.
Publicado: (2018)

Efficacy and safety of vesatolimod in chronic hepatitis B: A systematic review and meta-analysis
por: Omer, Ibrahim, et al.
Publicado: (2023)

Efficacy and safety of autologous hematopoietic stem cell therapy for refractory Crohn's disease: A systematic review and meta-analysis
por: Qiu, Xiao, et al.
Publicado: (2017)

Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis
por: Zhao, Xiaojing, et al.
Publicado: (2017)

Efficacy and safety of ERCP in patients with gastroesophageal varices
por: Hong, Junbo, et al.
Publicado: (2020)

Efficacy and Safety of Antiintegrin Antibody for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Lin, Lianjie, et al.
Publicado: (2015)

Efficacy and safety of Yinchenwuling Powder for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Wu, Peishan, et al.
Publicado: (2022)

Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer
por: Li, Guodong, et al.
Publicado: (2021)

Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis
por: Yao, Liwei, et al.
Publicado: (2017)

Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer
por: Ma, Junxun, et al.
Publicado: (2017)

Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)
por: Suenaga, Mitsukuni, et al.
Publicado: (2015)

Efficacy and safety of therapeutic ERCP in patients with ectopic papilla of Vater
por: Hong, Junbo, et al.
Publicado: (2020)

Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Efficacy and safety evaluation of acupoint embedding for patients with ulcerative colitis: A protocol of systematic review and meta-analysis
por: Lu, Jinhua, et al.
Publicado: (2020)

Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study
por: Scheiner, Bernhard, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r5l8q6t2kt230rs2t2nnr1vn5b